EP 15. Jasper Littmann & policy on AMR. Preclinical pipeline. Development challenges.
2020-01-13
Welcome to the "new" roaring 20s! Celebrate the new year and decade with us by listening to our latest episode, featuring an interview with Dr. Jasper Littmann, Specialist Director for Strategy and Development at the Norwegian Institute of Public Health. In this interview, we learn how an ethicist works when translating knowledge into action within policy making, the challenges in communicating with policy makers, and how the AMR field has changed in the last years. In the news section, we cover two back-to-back publications reviewing the preclinical pipeline and discussing antibiotic development challenges.
You can follow us and subscribe to our podcast to get new episodes directly in your preferred device and platform:
or you can listen to our fithteenth episode right here:
Relevant Links:
- Dr. Littmann twitter feed.
Further Reading:
- The global preclinical antibacterial pipeline. First publication covered in the news section.
- Antibiotic development - economic, regulatory and societal challenges. Second publication covered in the news.
If you have any comments and suggestions you can email us here, or tweet to us (@UAC_UU) using the hashtag #theAMRStudio.